Back
Open Access

Improving outcomes for the heart and kidney: the role of mineralocorticoid receptor antagonists (MRAs)

Session: Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
Topic: Treatment
Speaker: Professor B. Bozkurt (Houston, US)
Sponsored by Charité Berlin - Supported by an unrestricted educational grant from Bayer
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Biykem Bozkurt

Baylor College of Medicine, Houston (United States of America)
52 presentations
9 followers

5 more presentations in this session

Welcome and introduction

Speaker: Professor M. Cikes (Zagreb, HR)

Access
Slides
Video
Like
Thumbnail

MRAs in heart failure with reduced rejection fraction (HFrEF): a cornerstone of guideline-recommended medical therapy

Speaker: Professor M. Cikes (Zagreb, HR)

Access
Slides
Video
Like
Thumbnail

Non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in heart failure with mid-range and preserved ejection fraction: establishing a new standard in heart failure care

Speaker: Professor J. Butler (Dallas, US)

Access
Slides
Video
Like
Thumbnail

nsMRAs: what emerging trials tell us about the future of heart failure therapy

Speaker: Professor J. McMurray (Glasgow, GB)

Access
Slides
Video
Like
Thumbnail

Panel discussion and conclusion

Access
Video
Like
Thumbnail

Access the full session

Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation

Speakers: Professor B. Bozkurt, Professor M. Cikes, Professor M. Cikes, Professor J. Butler, Professor J. McMurray
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources